Global Phosphodiesterase (PDE) Inhibitors Market 2021 Growth, COVID Impact, Trends Analysis Report 2027
The global phosphodiesterase (PDE) inhibitors market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The PDE is found in the cytosol, plasma membranes, endoplasmic reticulum, nuclear membranes, and cytoskeleton. Majorly, the two types of PDE inhibitors including the selective and non-selective are being discovered as possible treatments for various indications, such as chronic obstructive pulmonary disease (COPD), Alzheimer’s disease, and other ailments. Thus, such novel application of these inhibitors in the treatment of various diseases is promising a strong market growth during the forecast period. Another pivotal factor that is driving the global PDE inhibitors market growth includes the rise in the prevalence of erectile dysfunction disorder. According to the World Health Organization, about 150 million people have been affected by erectile dysfunction across the globe and the number is projected to reach 230 million by 2025. It is a common medical condition affecting about 15% of men each year.
To Request a Sample of our Report on Global
Phosphodiesterase (PDE) Inhibitors Market: https://www.omrglobal.com/request-sample/phosphodiesterase-pde-inhibitors-market
Some key players operating in the market include
Bayer AG, Eli Lilly and Co., GlaxoSmithKline Plc, and Pfizer Inc., among others.
These players are eyeing to strengthen their position in the market by adopting
various strategies as mergers and acquisitions, partnerships, collaborations,
new product launch and development in the existing product portfolio, and so
on. For instance, in July 2018, Adamis Pharmaceuticals Corp. (Adamis) announced
that it has been conducting pre-IND development work for a fast-dissolving
sublingual tablet containing tadalafil, which is a drug used to treat erectile
dysfunction. Further, in September 2020, Aspargo Laboratories, Inc. acquired
the international rights to Sildenafil oral spray for the treatment of erectile
dysfunction.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Bayer AG, Eli Lilly and Co., GlaxoSmithKline
Plc, and Pfizer Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Phosphodiesterase (PDE) Inhibitors Market is Available
at: https://www.omrglobal.com/industry-reports/phosphodiesterase-pde-inhibitors-market
Global Phosphodiesterase (PDE) Inhibitors Market by Segmentation
By Type
• Selective PDE
Inhibitors
·
PDE-1
·
PDE-2
·
PDE-3
·
PDE-4
·
PDE-5
·
Others
• Non-Selective PDE
Inhibitors
By Route of Administration
• Oral
• Topical
• Others
By Application
• CVD
• Erectile Dysfunction
• Pulmonary Hypertension
• Respiratory Disease
• Benign Prostate
Hyperplasia
• Others
Global Phosphodiesterase (PDE) Inhibitors Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment